Literature DB >> 10716312

Cerebellar vasoreactivity in stroke patients with crossed cerebellar diaschisis assessed by acetazolamide and 99mTc-HMPAO SPECT.

S E Kim1, M C Lee.   

Abstract

UNLABELLED: Crossed cerebellar diaschisis (CCD) tends to persist or even worsen after supratentorial infarction. Several studies have shown impairment of cerebral vasomotor responsiveness in the hemispheric area of diaschisis in patients with hemispheric infarction. This finding has led to the concern that the lack of CCD reversibility might be associated with chronic circulatory abnormalities. We therefore assessed the vasoreactivity in the cerebellar hemisphere in which diaschisis is manifested using acetazolamide (ACZ) and SPECT.
METHODS: Eight stroke patients with CCD (5 with unilateral hemispheric infarcts and 3 with unilateral intracerebral hemorrhage) had 99mTc-HMPAO SPECT scanning at rest and 20 min after intravenous injection of 1.0 g ACZ. The time interval after stroke ranged from 25 to 904 d. From the total counts obtained from each cerebellar hemisphere, the asymmetry index (AI) was calculated as (unaffected - affected cerebellar hemisphere)/unaffected cerebellar hemisphere x100.
RESULTS: After ACZ, the mean AI (8.7+/-6.6) was significantly decreased (P<0.05) compared with that at rest (17.7+/-5.8). Seven of the 8 patients showed decrease in the AI after ACZ. In 1 patient, the direction of the asymmetry was reversed after ACZ so that the AI was negative. The ACZ-induced change in the AI did not show a significant correlation with the time interval after stroke, whether calculated in absolute terms or as a percentage change.
CONCLUSION: This study shows that normal vascular supply is maintained in the CCD-affected cerebellar hemisphere over long periods of time after a stroke. Thus, the lack of CCD reversibility may not be attributed to a chronic circulatory insufficiency. The results lend support to the concept of functional deactivation and subsequent transneuronal degeneration as a likely explanation for CCD. It is unclear whether decreased AI after ACZ indicates a higher vascular response of the affected cerebellar hemisphere than that of the normal side.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716312

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Changes of fractional anisotropy and RGMa in crossed cerebellar diaschisis induced by middle cerebral artery occlusion.

Authors:  Yong Zhang; Xiao Wang; Jingliang Cheng; Yanan Lin; Lu Yang; Zhenghao Cao; Yunjun Yang
Journal:  Exp Ther Med       Date:  2019-09-09       Impact factor: 2.447

2.  Crossed cerebellar diaschisis after stroke identified noninvasively with cerebral blood flow-weighted arterial spin labeling MRI.

Authors:  Megan K Strother; Cari Buckingham; Carlos C Faraco; Daniel F Arteaga; Pengcheng Lu; Yaomin Xu; Manus J Donahue
Journal:  Eur J Radiol       Date:  2015-11-10       Impact factor: 3.528

3.  Whole-brain 320-detector row dynamic volume CT perfusion detected crossed cerebellar diaschisis after spontaneous intracerebral hemorrhage.

Authors:  Jun Fu; Wei-jian Chen; Gui-yun Wu; Jing-liang Cheng; Mei-hao Wang; Qichuan Zhuge; Jian-ce Li; Qian Zhang; Yong Zhang; Neng-zhi Xia; Yun-jun Yang
Journal:  Neuroradiology       Date:  2014-11-09       Impact factor: 2.804

Review 4.  60 Years of Achievements by KSNM in Neuroimaging Research.

Authors:  Jae Seung Kim; Hye Joo Son; Minyoung Oh; Dong Yun Lee; Hae Won Kim; Jungsu Oh
Journal:  Nucl Med Mol Imaging       Date:  2022-01-15

5.  Magnetic resonance perfusion imaging evaluation in perfusion abnormalities of the cerebellum after supratentorial unilateral hyperacute cerebral infarction.

Authors:  Pan Liang; Yunjun Yang; Weijian Chen; Yuxia Duan; Hongqing Wang; Xiaotong Wang
Journal:  Neural Regen Res       Date:  2012-04-25       Impact factor: 5.135

6.  Simultaneous PET-MRI imaging of cerebral blood flow and glucose metabolism in the symptomatic unilateral internal carotid artery/middle cerebral artery steno-occlusive disease.

Authors:  Bixiao Cui; Tianhao Zhang; Yan Ma; Zhongwei Chen; Jie Ma; Lei Ma; Liqun Jiao; Yun Zhou; Baoci Shan; Jie Lu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-06       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.